Consensus Cardlytics, Inc.

Stocks

CDLX

US14161W3034

Software

Market Closed - Nasdaq 16:00:00 2026-08-17 EDT			5-day change	1st Jan Change
4.050 ^USD	-4.26%		+6.58%	-64.78%

08-07	BofA Adjusts Price Target on Cardlytics to $4 From $8	MT
08-05	Cardlytics, Inc., Q2 2026 Earnings Call, Aug 05, 2026

Evolution of the Average Target: Cardlytics, Inc.

Evolution of the Target Price: Cardlytics, Inc.

Changes in Analyst Recommendations: Cardlytics, Inc.

1ac.Ig8Lnri36sudmSLkv31rlnHLPEpqINJUM3JtKMejpno.emJ8qM773ZjRwVulxRgo-jSITR4SUrAtRSQCapjlwSxnP0Hv9_vdj_fRSQ~12e8b9cae0a77a09fcc9ff1bcc6dea03

Analysts' recommendations: Cardlytics, Inc.

08-07	BofA Adjusts Price Target on Cardlytics to $4 From $8	MT
25-09-24	Cardlytics Shares Rise After Citron Research Says Company Has Multiple Opportunities to Rebuild	MT
25-08-06	Commerce media platform Cardlytics Q2 revenue falls just shy of estimates, adjusted EBITDA positive	RE
24-08-08	Lake Street Downgrades Cardlytics to Hold From Buy, Adjusts PT to $5 From $18	MT
24-08-08	Needham Downgrades Cardlytics to Hold From Buy	MT
24-05-09	Craig-Hallum Adjusts Cardlytics Price Target to $12 From $18, Maintains Buy Rating	MT
24-05-09	Needham Adjusts Price Target on Cardlytics to $12 From $17, Keeps Buy Rating	MT
24-04-09	Needham Raises Cardlytics' Price Target to $17 From $15, Maintains Buy Rating	MT
24-03-15	Craig-Hallum Upgrades Cardlytics to Buy From Hold, Adjusts Price Target to $18 From $10	MT
24-03-15	Lake Street Adjusts Cardlytics' Price Target to $18 From $13, Maintains Buy Rating	MT
23-11-29	Lake Street Starts Coverage on Cardlytics with Buy Rating, $13 Price Target	MT
23-08-02	Needham Adjusts Price Target on Cardlytics to $19 From $10, Maintains Buy Rating	MT
23-05-05	Needham Adjusts Price Target on Cardlytics to $10 From $8, Maintains Buy Rating	MT
23-04-12	Wells Fargo Adjusts Price Target on Cardlytics to $6 From $5, Keeps Underweight Rating	MT
23-03-02	JPMorgan Adjusts Cardlytics Price Target to $6 From $7, Maintains Neutral Rating	MT
23-03-02	Wells Fargo Adjusts Price Target on Cardlytics to $5 From $6, Keeps Underweight Rating	MT
23-03-02	Needham Lowers Price Target on Cardlytics to $8 From $14, Maintains Buy Rating	MT
23-01-09	Wells Fargo Adjusts Price Target on Cardlytics to $6 From $10, Maintains Underweight Rating	MT
22-11-02	Needham Adjusts Price Target on Cardlytics to $14 From $19, Maintains Buy Rating	MT
22-11-02	Wells Fargo Adjusts Cardlytics Price Target to $10 From $13, Maintains Underweight Rating	MT
22-09-08	Wells Fargo Downgrades Cardlytics to Underweight From Equalweight, Trims Price Target to $13 From $14	MT
22-08-03	Wells Fargo Trims Cardlytics Price Target to $14 From $15, Maintains Equalweight Rating	MT
22-08-03	Needham Adjusts Cardlytics' Price Target to $19 From $24, Reiterates Buy Rating	MT
22-07-14	Wells Fargo Downgrades Cardlytics to Equalweight From Overweight, Adjusts Price Target to $15 From $72	MT
22-07-13	Needham Adjusts Cardlytics' Price Target to $24 from $60, Keeps Buy Rating	MT

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	CARDLYTICS, INC.					+41.84%
	MICROSOFT CORPORATION					+14.97%
	PALANTIR TECHNOLOGIES INC.					+10.14%
	DATADOG, INC.					+11.63%
	CADENCE DESIGN SYSTEMS, INC.					+24.28%
	SYNOPSYS, INC.					+33.1%
	SEA LIMITED					+26.91%
	TAKE-TWO INTERACTIVE SOFTWARE, INC.					+16.17%
	ATLASSIAN CORPORATION					+15.85%
	TWILIO INC.					+4.99%
	Average					+19.99%
	Weighted average by Cap.					+15.10%